Investigators analyzed retinal hemorrhages and macular edema events in patients treated with roxadustat or darbepoetin alfa. The risk of developing ophthalmic abnormalities appears no higher with ...
A 47-year-old man with end-stage renal disease (ESRD), type 2 diabetes mellitus, hypertension, and coronary artery disease was started on peritoneal dialysis (PD) 2 years prior after a renal allograft ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today presented positive results from the Phase IIIb DIALIZE trial which investigated the efficacy and safety of LOKELMA (sodium zirconium cyclosilicate) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback